Skip to main content
Equibles

ALPS ADVISORS INC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1376113 Denver, CO
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$2,228,789
+$615,065 QoQ
Shares Held
60,059
+25.9% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#81
of 238 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. AGIO ranks #31 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2 APGE
Apogee Therapeutics, Inc.
 62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in AGIO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,228,789 60,059
2026-03-31 $1,613,724 47,701
2025-12-31 $1,303,320 47,881
2025-09-30 $1,106,017 27,554
2025-06-30 $1,040,173 31,274
2025-03-31 $1,237,016 42,219
2024-12-31 $1,515,207 46,111
2024-09-30 $1,910,756 43,006
2024-06-30 $1,909,871 44,292
2024-03-31 $1,159,073 39,640
2023-12-31 $842,785 37,844
2023-09-30 $1,017,200 41,099
2023-06-30 $1,157,041 40,856
2023-03-31 $836,613 36,422
2022-12-31 $1,045,839 37,245
2022-09-30 $847,127 29,955
2022-06-30 $720,591 32,503
2022-03-31 $1,634,817 56,160
2021-12-31 $2,065,846 62,849
2021-09-30 $3,334,522 72,254
2021-06-30 $4,452,777 80,798
2021-03-31 $6,470,595 125,302
2020-12-31 $5,412,653 124,917